Events

PLG Summer Meeting

Event Details

  • Location: London
  • Date: Thursday 30th June 2022
  • Price: £Free
    (Non-Members: £50.00)

Can you build a business on IP you can’t or don’t patent?

Our regular free to PLG members event will be held in London on Thursday 30 June 2022 at The Institute of Cancer Research’s Chester Beatty Labs.

Attendees are invited to arrive from 4.30pm for registration, with the afternoon presentations starting from 5pm. We are pleased to  confirm our great line up of speakers:

5.10pm – David Copping, Partner, Farrer & Co

Identifying and commercialising non-patented IP: the legal framework

  • Spotting and capturing value
  • Dealing with data, software, algorithms and analytics
  • Know-how and trade secrets
  • The power of brands

5.35pm – Bruce Hellman, Co Founder & Chief Patient Officer, uMotif

uMotif – our IP journey from digital health startup to eClinical software platform for clinical trials

  • What we’ve protected
  • What we can’t
  • How to build non-protectable value
  • Opportunities for pharma
  • Focusing on the real ‘job to be done’

6pm – Simon Rasalingham, Chairman & CEO, behold.ai

AI accelerated diagnosis from behold.ai – why should big Pharma be interested?

6.25pm – Summary

6.30pm – Networking drinks reception

8.30pm – Close

To book your place please visit PLG Summer Meeting Online Registration

Guest places are available for a small registration fee.

Event Sponsors

Event Schedule

Thursday 30 June 2022

4.30pm Registration
5pm Welcome & PLG Update
5.05pm Introduction
JON WILKINSON
Deputy Director and Head of Business Development and Licensing
The Institute of Cancer Research
Chair
TOBY RICHARDSON
Senior Director, Early Innovation Partnering Immunology, EMEA
Johnson & Johnson Innovation
5.10pm Presentation 1
DAVID COPPING
Partner
Farrer & Co

Identifying and commercialising non-patented IP: the legal framework

Spotting and capturing value
Dealing with data, software, algorithms and analytics
Know-how and trade secrets
The power of brands
5.35pm Presentation 2
BRUCE HELLMAN
Co-Founder & Chief Patient Officer
uMotif

uMotif - our IP journey from digital health startup to eClinical software platform for clinical trials

What we've protected
What we can't 
How to build non-protectable value
Opportunities for pharma
Focusing on the real 'job to be done'
6pm SIMON RASALINGHAM
Chairman & CEO
behold.ai

AI accelerated diagnosis from behold.ai - why should big Pharma be interested?
6.25pm Summary & Wrap-up
6.30pm Networking Drinks Reception
8.30pm Close

Venue & Accommodation

Full Venue Address

Institute of Cancer Research
Chester Beatty Labs
237 Fulham Road
London
SW3 6JB

View Map

Event Downloads

You must be logged in to access the downloads.